Urologix, Inc.
ULGX
$0.0001
$0.000.00%
| 03/31/2015 | 12/31/2014 | 09/30/2014 | 06/30/2014 | 03/31/2014 | |
|---|---|---|---|---|---|
| Net Income | 12.42% | -28.09% | -47.27% | -77.26% | -24.85% |
| Total Depreciation and Amortization | -18.67% | -16.01% | -14.42% | -12.91% | -9.68% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 161.34% | 491.32% | 566.36% | 663.32% | 243.81% |
| Change in Net Operating Assets | -42.56% | -63.67% | -12.91% | 6.50% | -82.17% |
| Cash from Operations | 90.77% | 68.65% | 57.61% | 21.90% | -461.74% |
| Capital Expenditure | 76.92% | 91.43% | 59.74% | 59.49% | 27.78% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -286.67% | -123.08% | 70.00% | 68.75% | 37.50% |
| Cash from Investing | 95.75% | 95.97% | 97.29% | 97.16% | -1,394.79% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | 98.31% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -100.03% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 92.44% | 79.60% | 73.51% | -502.05% | -232.10% |
